Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

Factors that aid survival of prostate cancer cells in the presence of the various categories of cytotoxic cytokines present in tumors in vivo are largely unknown. Osteoprotegerin (OPG) is a decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) that inhibits TRAIL-induced...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Holen, I, Croucher, P, Hamdy, F, Eaton, C
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2002

Những quyển sách tương tự

Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
Bằng: Eaton, C, et al.
Được phát hành: (2004)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
Bằng: Eaton, C, et al.
Được phát hành: (2004)

OPG is a survival factor for breast- and prostate cancer cells in vitro
Bằng: Holen, I, et al.
Được phát hành: (2002)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
Bằng: Holen, I, et al.
Được phát hành: (2002)

Role of osteoprotegerin (OPG) in cancer.
Bằng: Holen, I, et al.
Được phát hành: (2006)

The role of osteoprotegerin in breast and prostate cancer
Bằng: Holen, I, et al.
Được phát hành: (2002)

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
Bằng: Holen Ingunn, et al.
Được phát hành: (2009-07-01)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
Bằng: Shipman, C, et al.
Được phát hành: (2002)

Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis
Bằng: Lili Zhang, et al.
Được phát hành: (2016-11-01)

Osteoprotegerin (OPG) is a soluble decoy receptor for TRAIL/Apo2L and can inhibit TRAIL/Apo2L-induced apoptosis of human myeloma cells in vitro.
Bằng: Shipman, C, et al.
Được phát hành: (2002)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
Bằng: Shipman, C, et al.
Được phát hành: (2000)

Serum osteoprotegerin (OPG) in children with primary nephrotic syndrome
Bằng: Gamal B Mohamed, et al.
Được phát hành: (2011-01-01)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
Bằng: Waterman, E, et al.
Được phát hành: (2007)

Polymorphisms within the osteoprotegerin (OPG) gene are associated with both serum OPG levels and bone mineral density.
Bằng: Miles, L, et al.
Được phát hành: (2004)

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2000)

Endogenous osteoprotegerin (OPG) represses ERα and promotes stemness and chemoresistance in breast cancer cells
Bằng: Noura N. Alraouji, et al.
Được phát hành: (2024-08-01)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
Bằng: Riham Eid, et al.
Được phát hành: (2023-06-01)

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
Bằng: Shipman, C, et al.
Được phát hành: (2003)

Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Bằng: Siamak Kazemi-Sufi, et al.
Được phát hành: (2024-09-01)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
Bằng: Nyambo, R, et al.
Được phát hành: (2004)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
Bằng: Nyambo, R, et al.
Được phát hành: (2004)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
Bằng: Chan Kai-Ming, et al.
Được phát hành: (2011-07-01)

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
Bằng: Syed Muhammad Muneeb Akhtar, et al.
Được phát hành: (2024-07-01)

Osteoprotegerin and the development of myeloma bone disease
Bằng: Croucher, P, et al.
Được phát hành: (2004)

Effects of osteoprotegerin from transfection of pcDNA3.1(+)/chOPG on bioactivity of chicken osteoclasts
Bằng: Yao Jing, et al.
Được phát hành: (2011-03-01)

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females
Bằng: Saba Tariq, et al.
Được phát hành: (2022-02-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
Bằng: Yosra Azizpour, et al.
Được phát hành: (2020-01-01)

Investigation of the effect of hydroalcoholic mumie extract on expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL)
Bằng: Yosra Azizpour, et al.
Được phát hành: (2020-01-01)

The survival effect of prolactin on PC3 prostate cancer cells.
Bằng: Ruffion, A, et al.
Được phát hành: (2003)

Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells
Bằng: Lara Absil, et al.
Được phát hành: (2021-04-01)

Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients
Bằng: Indra Wijaya, et al.
Được phát hành: (2024-01-01)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Bằng: Croucher, P, et al.
Được phát hành: (2003)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Bằng: Croucher, P, et al.
Được phát hành: (2001)

Determinant Factors and Added Value of Osteoprotegerin (OPG) to Detect Carotid Intima-Media Thickness (CIMT) in Type 2 Diabetes Mellitus Patient
Bằng: Shirly Elisa Tedjasaputra, et al.
Được phát hành: (2018-06-01)

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids
Bằng: Salvador Atilano-Miguel, et al.
Được phát hành: (2022-01-01)

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis
Bằng: Lane Denis, et al.
Được phát hành: (2012-11-01)

Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
Bằng: Martin Widschwendter, et al.
Được phát hành: (2015-10-01)

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells
Bằng: Cross, N, et al.
Được phát hành: (2008)

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
Bằng: Cross, N, et al.
Được phát hành: (2008)

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.
Bằng: Vanderkerken, K, et al.
Được phát hành: (2003)